Sid Katugampola
Centre for Drug Development at Cancer Research, UK
Biography
Sid Katugampola completed his PhD in Cambridge. He worked across multiple departments, spanning over 11 years at Pfizer Research UK. During his last 6 years at Pfizer he led projects in biomarkers and translational medicine across multiple therapeutic areas and targets. The past 3 years of his career he has been working at the Centre for Drug Development at Cancer Research UK, where he is responsible for delivering pharmacodynamic biomarkers, across multiple modalities and cancer types, in early phase oncology clinical trials, the majority of which are first in class agents.
Abstract
Abstract : Biomarkers in early phase oncology clinical development
Speaker Presentations
Speaker PPTs Click Here